Exsure
PrivateLast Round
Seed
Jan 22, 2025
Total Funding Raised
$349,000
Company Overview
Exsure is a biotechnology company that develops an exosome-based drug delivery platform for targeted cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exsure Comps
Public and private peers based on sector, stage, and business model.
Exsure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 22, 2025 |
Key People
Founding team and executive leadership
Exsure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IIT Mandi Catalyst | Seed |
| Unicorn India Ventures | Seed |
| Venture Center | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Monthly visitors increased 79% MoM.
- Nov 8, 2025
Monthly visitors increased 80% MoM.
Exsure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exsure's valuation, stock price, and market status.
